Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Meridian Bioscience Inc (VIVO)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Meridian's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Meridian historical data, for real-time data please try another search
33.97 0.00    0.00%
30/01 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 33.93 - 34.02
Meridian 33.97 0.00 0.00%

Meridian Bioscience Inc Company Profile

 
Get an in-depth profile of Meridian Bioscience Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
Industry
Sector
Employees

704

Equity Type

ORD

Meridian Bioscience, Inc. operates as a life science company that develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The company operates through diagnostics and life science segments. The Diagnostics segment offers testing platforms that include real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brands. This segment also offers respiratory illness assays, such as tests for Group A strep, mycoplasma pneumonia, influenza, and pertussis, and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through a direct sales force and independent distributors to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies. The Life Science segment offers antigens, antibodies, PCR/qPCR reagents, isothermal reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was formerly known as Meridian Diagnostics, Inc. and changed its name to Meridian Bioscience, Inc. in January 2001. Meridian Bioscience, Inc. was incorporated in 1976 and is based in Cincinnati, Ohio with additional offices in Memphis, Tennessee; Quebec, Canada; Beijing, China; Luckenwalde, Germany; Modiin, Israel; Milan, Italy; and London, United Kingdom. The company operates as a subsidiary of SD Biosensor, Inc.

Contact Information

Address 3471 River Hills Drive
Cincinnati, 45244
United States
Phone 513 271 3700
Fax 513 271 3702
Web www.meridianbioscience.com
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

VIVO Comments

Write your thoughts about Meridian Bioscience Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
kc monk
kc monk Oct 20, 2021 5:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Wake up vivo, just show your power
Reply
0 0
Report
Carlos Andres
Carlos Andres Dec 15, 2020 12:52PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
time to hold or sell?
Reply
1 0
Report
Carlos Andres
Carlos Andres Dec 15, 2020 12:52PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I will hold until 24 dollars
Reply
2 0
Report
Carlos Andres
Carlos Andres Dec 11, 2020 9:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
strong?
Reply
0 0
Report
John Simmons Simmons
John Simmons Simmons Feb 12, 2020 2:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
do you think Meridian Bioscience Inc, will discover the Meridian the vaccine of COVID19 ?
Reply
2 2
Report
John Simmons Simmons
John Simmons Simmons Jan 18, 2020 10:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
vivo is it worth to entry for short term ?
Reply
2 0
Report
Jose Urbina
Jose Urbina Jan 18, 2020 10:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
just during the epidemic coronavirus!!
Reply
0 2
Report
Jose Urbina
Jose Urbina Jan 18, 2020 10:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
just during the epidemic coronavirus!!
Reply
0 1
Report
John Simmons Simmons
John Simmons Simmons Jan 18, 2020 10:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Jose Urbina Dear Mr. Jose Urbina do you suppose Meridian Bioscience they will discover the vaccine of COVID19 ? what do you think Sir ?
Reply
0 1
Report
Dmitry Fishbeyn
Dmitry Fishbeyn Jun 07, 2019 12:00PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
crickets??
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email